Evaluation of Allium ampeloprasum cream effect for the management of hemorrhoids symptoms

Not Applicable

• Conditions: hemorrhoids.; Unspecified haemorrhoids with other complications

• Registration Number: IRCT2014010816143N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

inclusion criteria:
1- Age: 18 Years to 65 Years
2- Participants who agree to participate in the current study
3- Participants having symptomatic hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination
4- Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period.
exclusion criteria:
1- Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer
2- Participants having hypersensitive predisposition or hypersensitive to Allium ampeloprasum or history of skin hypersensivity
3- Female participants under pregnancy or during breastfeeding period
4- Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis
g- history of steroid or anticoagulant drug consumption

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale.;Bleeding. Timepoint: 3 weeks after intervention. Method of measurement: questionare.;Itching. Timepoint: 3 weeks after intervention. Method of measurement: questionare.;Deficate discomfort. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale.;Total improvment. Timepoint: 3 weeks after intervention. Method of measurement: visual analogue scale.

Secondary Outcome Measures

Name	Time	Method
Constipation. Timepoint: 3 weeks after intervention. Method of measurement: questionare.